Home › Pulmonary Arterial Hypertension › North Carolina › Durham
Pulmonary Arterial Hypertension clinical trials in Durham, NC
7 studies for Pulmonary Arterial Hypertension are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 3
- Duke University, Durham
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
RecruitingObservational studyHealthy volunteers welcome
- Duke University Health System, Durham
Xenon MRI Pulm Hypertension
RecruitingPhase 2
- Duke University Medical Center, Durham
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 2
- Duke University Medical Center, Durham
Pulmonary Hypertension SOLAR
RecruitingPhase 2
- Duke University Medical Center, Durham
129 Xenon Imaging in Patients Treated With Sotatercept
RecruitingPhase 2
- Duke University Medical Center, Durham
Pulmonary Hypertension Association Registry
RecruitingObservational study
- Duke University Medical Center, Durham
- UNC Chapel Hill, Chapel Hill · 10 mi away
Pulmonary Arterial Hypertension trials in other cities
- Cincinnati, OH7 studies
- Mountain View, CA7 studies
- Kansas City, KS7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Nashville, TN7 studies
- Philadelphia, PA6 studies
- New York City, NY5 studies
- Seattle, WA5 studies
- Houston, TX4 studies
- Louisville, KY4 studies
- Dallas, TX4 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.